Status:
RECRUITING
Virtual Reality Exposure Therapy for Obsessive-Compulsive Disorder: Outpatients Trial
Lead Sponsor:
National Institute of Mental Health, Czech Republic
Conditions:
Obsessive-compulsive Disorder
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the efficacy of virtual reality exposure therapy (VRET) as a treatment for obsessive-compulsive disorder (OCD). This study focuses on patients receiving treatment ...
Detailed Description
The virtual environment of so called "OCD house" is used as a tool for the therapy. Immersive VR glasses Meta Quest 2 are used to visualize the environment. During exposure therapy, relevant virtual ...
Eligibility Criteria
Inclusion
- Diagnosis of OCD (F42) using currently valid DSM-V and ICD-11
- Fluent in Czech
Exclusion
- Any other psychiatric, neurological and serious somatic illness
- Substance abuse
- Psychotropic medication (e.g. benzodiazepines) except antidepressants, antipsychotic medication and hypnotics.
- Contradictions to using a virtual reality (e.g., epilepsy, balance problems)
- Pregnancy
- Cardiostimulator and mental implants
Key Trial Info
Start Date :
March 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07206199
Start Date
March 20 2024
End Date
March 31 2027
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nationa Institute of Mental Health
Klecany, Česká Republika, Czechia, 250 67